Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROA

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at Meridian Bioscience

is 21.19%. Meridian Bioscience had $44.28 million in total cash for the latest quarter. The trailing-twelve-month return on assets at SurModics

is 11.09%. SurModics's revenue for the same period is $56.13 million. The trailing-twelve-month return on assets at Neogen

is 8.91%. Neogen's operating margin for the same period is 18.65%. The trailing-twelve-month return on assets at Abaxis

is 8.08%. Abaxis's ROE for the same period is 10.40%.